GenoLogics Unveils Clarity
LIMS for CLIA-Certified Next Generation Sequencing Labs
Clarity LIMS brings intuitive interface and lab
management essentials to regulated labs
VIENNA, Austria – Bio-IT World Europe
Conference – October 9, 2012 – GenoLogics Life Sciences Software, a leading
provider of laboratory information management systems (LIMS) designed for today’s
omics labs, unveiled Clarity LIMS, a revolutionary LIMS that sets the bar for
LIMS in clinical and research environments. Specifically designed for sequencing,
Clarity LIMS is an intuitive lab management system that combines information
management essentials for CLIA-certified and regulated labs with a clear and
easy-to-navigate interface that scientists will want to use.
Clarity LIMS offers support for clinical lab
directors as they work on achieving or maintaining CLIA certification. Specifically,
Clarity LIMS assists lab directors with workflow enforcement, adherence to standard
operating procedures and handling the complexities of next-generation
sequencing (NGS). Designed to manage the flow of samples through the lab, the
new role-optimized interface will become a planning tool thereby enhancing lab
efficiency.
“The Clarity LIMS interface is highly
intuitive, largely because it is set up to follow the logical flow of a sample
moving through the wet lab,” stated Marc Laurent, Director of Genomic Services at
Illumina, a Clarity LIMS customer. “This aspect, coupled with the fact that it
can be used for planning lab work will significantly increase user adoption. We
have looked at many LIMS over the past few years, and the Clarity LIMS user
experience surpasses all others.”
“Clearly a lot of
thought has been put into making the interface as intuitive and friendly as
possible even for complex processing steps. It’s nicely executed too ─ the interface
looks and behaves great,” stated Conrad Leonard, bioinformatics engineer at
Queensland Center for Medical Genomics.
“The launch of Clarity LIMS is timely, given
the speed at which the sequencing market is moving into the clinical space,”
noted Tristan Orpin, Illumina’s Senior Vice President and Chief Commercial
Officer and a member of GenoLogics’ Board of Directors. “The new GenoLogics
software tightly integrates to our sequencing instruments and includes support
for all of our standard workflows and kits. We see great growth potential in
the clinical market for products like this that ease the transition of NGS into
the clinic.”
Customers have been providing real-time
feedback on Clarity LIMS to GenoLogics development team over the last year. Clarity LIMS is now commercially available and
GenoLogics has already secured commitments from four labs to implement Clarity
LIMS.
“In designing and building Clarity LIMS,
GenoLogics drew on more than a decade of experience developing software for
omics technologies,” said Michael Ball, CEO of GenoLogics. “We relentlessly focused
on ways to empower customers working in regulated NGS laboratories and to
provide a system that simplifies the tracking of these complex technologies by
providing an intuitive interface. Lab directors who choose Clarity LIMS will
see immediate tangible value out of their investment. Not only does Clarity LIMS raise the bar in terms of support
for regulated environments, but lab staff will actually enjoy using
it.”
